Day: June 10, 2022

Selskabsmeddelelse Nr. 11/2022 10. juni 2022 Indeholder intern videnDanske Erria har vundet selskabets største kontrakt nogensinde med Ørsted og opjusterer i denne forbindelse guidance med 2 mio. kr. Kontrakten er femårig med mulighed for forlængelse i yderligere to år. Ørsted Bioenergy & Thermal Power A/S (Ørsted) estimerer kontraktsummen til maksimalt 450.000.000 DKK.Med den historisk store Ørsted-kontrakt åbner offshore-konglomeratet med base på det historiske handelstorv i Køge et nyt kapitel i selskabets 30-årige historie. Erria A/S (“Erria” eller “selskabet”) har tidligere gennem 15 år indtil 2017 leveret drift, service, risikostyring og sikkerhedsudstyr til Ørsted, og nu er Danmarks største energivirksomhed igen at finde på kundelisten.CEO Henrik N. Andersen ser frem til igen at servicere en af Danmarks største virksomheder...

Drawing of a tranche of ORNAN of €1 million in nominal value Dardilly, June 10, 2022 – 6.30 pm As announced on May 10, 2022, by way of a press release, the second part of the financing transaction agreed between Delta Drone and Yorkville Advisors results in the draw today of the second tranche of € 1 million, accompanied by the immediate purchase by Delta Drone of the attached BSAs for a total price of € 1. These BSAs will be cancelled. In accordance with the delegation of competence conferred on the Board of Directors by the Extraordinary General Meeting of Shareholders of Delta Drone (the “Company“) on April 24, 2020 under the terms of its 6th resolution, the Board of Directors has, on October 14, 2020:approved the principle of an issue of 2,500 warrants (the “Warrants“), which will give rise, on exercise, to...

Saint-Herblain (France), June 10, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today provides an update on its European inactivated whole-virus COVID-19 vaccine candidate VLA2001. Following receipt of the European Commission (EC)’s notice of intent to terminate the Advance Purchase Agreement (APA)1, Valneva proposed a remediation plan, which is now subject to further discussion within the EC and among the participating member states. Some member states have confirmed their interest in having an inactivated, adjuvanted whole-virus vaccine solution in their portfolio. However, the preliminary, unofficial volume indications received from the EC would not be sufficient to ensure the sustainability of Valneva’s COVID-19 vaccine program. This would also impede the future development of the program beyond...

CHARLOTTE, N.C., June 10, 2022 (GLOBE NEWSWIRE) — Glatfelter Corporation (NYSE: GLT) a leading global supplier of engineered materials, today announced that Dante C. Parrini, Chairman and Chief Executive Officer, and Ramesh Shettigar, Senior Vice President, Chief Financial Officer and Treasurer, will be presenting at the Sidoti & Company Summer Small Cap Virtual Conference on Thursday June 16, 2022. Glatfelter’s presentation will begin at 10:45 am Eastern Time. In addition, management will conduct one-on-one meetings with conference participants. A copy of the Company’s presentation, along with the webcast link, will be available on Glatfelter’s Investors page located at Webcasts and Presentations – Glatfelter Engineered Materials. About Glatfelter Glatfelter is a leading global supplier of engineered materials with...

New York, NY, and Tel Aviv, ISRAEL, June 10, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. reported a Day 45 update from an ongoing case study by Dr. Lee Morgentaler of a 3CL protease cleanse with Tollovid, a 3CL protease inhibitor dietary supplement, in a patient who originally contracted COVID in February 2021 and experienced symptoms of Long COVID. ABSTRACT:The subject is a 46-year-old, 6’0”, 210 pounds, unvaccinated male who describes his premorbid condition as healthy with 5 days per week of vigorous exercise and held a physically demanding job. By report, his blood pressure was 120/75 with a resting heart rate of 60 bpm. He tested positive for COVID-19...

ORION CORPORATION  STOCK EXCHANGE RELEASE 10 JUNE 2022 7:15 p.m. EEST                  Charges pressed by prosecutor against a member of Orion’s Board of Directors for a suspected securities market offence dismissed Charges pressed by prosecutor against a member of Orion’s Board of Directors for a suspected securities market offence dismissed It has come to the attention of Orion Corporation the charges pressed by prosecutor against Ari Lehtoranta, a member of Orion’s Board of Directors, in a securities markets case concerning suspected disclosure offence have been dismissed. According to Orion’s knowledge, the matter was related to Mr. Lehtoranta’s operations as the CEO of Nokian Tyres plc in 2015-2016. Orion Corporation disclosed the prosecutor’s decision to press charges in its stock exchange release of 29 October 2020. The suspected...

AFM28 induced potent, effective, and specific anti-tumor activity against CD123-positive cells irrespective of mutational status Study demonstrated specific anti-tumor response even at low levels of CD123 expression with no evidence for off-target cytotoxic activity towards CD123-negative healthy bone marrow progenitors In vivo studies of an AML murine model demonstrated anti-tumor efficacy; cynomolgus toxicology models showed pharmacodynamic activity with a well-tolerated safety profile suggesting a low risk of cytokine release First-in-human phase 1 clinical trial of AFM28 monotherapy expected to begin in 2H 2022HEIDELBERG, Germany, June 10, 2022 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD) (“Affimed” or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight...

NEW YORK, NY, June 10, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Emergency Response Technologies Inc (ERT) is a public safety acquisitions company focused on disruptive technology which protects assets and saves lives. Mergers and Acquisitions company, ILUS International (OTC: ILUS), currently owns 100% of ERT, which was created as a public safety focused subdivision of ILUS. ERT announced today that it has appointed the experienced Dan Peters as its CEO.  “Dan is the right leader to implement our aggressive ERT growth strategy. He brings extensive emergency response and manufacturing experience to the board and is incredibly well-known in the firefighting industry. Having spent some time getting to know Dan recently, I am most impressed with his passion for the industry, his zealousness when it comes to business development,...